What is Resurrect Bio?
Resurrect Bio operates at the intersection of synthetic biology and crop science. Spun out of the prestigious Sainsbury Laboratory in Norwich, the company focuses on identifying and reintroducing native resistance genes from wild and heritage plant varieties into modern crops. This approach provides a robust, biological alternative to traditional chemical-based crop protection methods. By addressing the systemic vulnerabilities in global food production, Resurrect Bio is effectively positioning itself as a foundational technology provider for the global seed industry, aiming to improve yield stability and environmental sustainability simultaneously.
How much funding has Resurrect Bio raised?
Resurrect Bio has raised a total of $20.4M across 3 funding rounds:
Unspecified
$2M
Series A
$8.1M
Series A
$10.3M
Unspecified (2023): $2M with participation from UKI2S, SynBioVen, AgFunder, and SHAKE Climate Change
Series A (2026): $8.1M led by Calculus Capital, SynBioVen, AgFunder, Corteva Agriscience, Uki2s, and Pymwymic
Series A (2026): $10.3M supported by Pymwymic, Calculus Capital, Future Planet Capital, AgFunder, Corteva Agriscience, SynBioVen, and Uki2s
Key Investors in Resurrect Bio
Pymwymic
A pioneering impact investment firm with over 30 years of experience, specializing in transformative technologies that restore broken food and agriculture systems.
Calculus Capital
A London-based investment manager focused on tax-efficient growth capital, providing essential funding to high-growth technology and healthcare businesses.
Future Planet Capital
An impact-led venture capital firm that bridges the gap between top-tier university research and commercial scalability to address global sustainability challenges.
What's next for Resurrect Bio?
With the successful closure of this latest financing round, Resurrect Bio is well-positioned to scale its R&D operations and accelerate the commercialization of its gene-edited traits. The company's strategic roadmap involves deepening its collaboration with global agricultural partners to integrate its proprietary technology into high-value crop pipelines. As the firm moves beyond its initial development phase, the focus will shift toward regulatory validation and large-scale field trials, ensuring that its sustainable solutions can meet the rigorous demands of modern, climate-resilient farming systems.
See full Resurrect Bio company page
